National Stock Number
6515-00-890-3518
National Stock Number (NSN) 6515-00-890-3518, or NIIN 008903518, (bronchoscope) was assigned May 5, 1972 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There is only one manufacturer part number associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 13843. [AN ITEM USED IN BRONCHOSCOPY AND ANESTHESIOLOGY PROCEDURES. IT IS COMPATIBLE FOR USE WITH LIGHT, ENDOSCOPIC INSTRUMENT, FIBER OPTIC AND CABLE ASSEMBLY, FIBER OPTIC. MAY INCLUDE A LIGHT CARRIER, SIZED CONNECTOR FOR ASPIRATION AND ONE INTERCHANGEABLE WINDOW PLUG.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no data in the HMIRS and the NSN is in an FSC not generally suspected of containing hazardous materials. NSN 6515008903518 does not contain precious metals.
This NSN is associated to Schedule B 9018194000: electro-diagnostic apparatus for functional exploratory examination, and parts and accessories thereof. The Schedule B End Use is listed as medicinal equipment. NAICS classification category 334510: electromedical and electrotherapeutic apparatus manufacturing.
This information was last updated on Jul 01, 2025.